FDA Recall Database: Class I Recall: Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00.… by Philips Respironics, Inc.

Key facts

What this classification means

A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00. Continuous home-use ventilator device. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Philips Respironics, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Philips Respironics, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Philips Respironics, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

Philips Respironics, Inc.’s FDA history

Argus HQ has recorded 50 total FDA actions tied to Philips Respironics, Inc.: 0 warning letters, 50 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Is Philips Respironics Trilogy Evo O2, Software Version 1.05.15 recalled?

Yes. FDA lists a Class I recall by Philips Respironics, Inc. for Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00. Continuous home-use ventilator device., reported 20260401, with status "Ongoing." FDA recall number: Z-1615-2026.

What is the recall class for Philips Respironics, Inc.'s recall?

FDA classified this recall as Class I. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death.

Why was Philips Respironics Trilogy Evo O2, Software Version 1.05.15 recalled?

FDA's recall record states the reason as: Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.

Who should I contact about this recall?

Contact Philips Respironics, Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.

Related enforcement actions

• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy Evo Universal, Software Version 1.05.15.00. Continuo… →
• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00. Continuous home… →
• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-us… →
• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-… →
• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-us… →
• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-… →
• Recall: Philips Respironics, Inc. — Class I recall: Philips Respironics Trilogy Evo Universal, Software Version 1.05.15.00. Continuo… →
• Recall: Philips Respironics, Inc. — Class II recall: SimplyGo Mini, Standard Battery Kit; Product code: 1116816; The affected bat… →